Ether

Ether

SCHEMBL6529480

CCOCC.c1ccc(-n2ccc3ccccc32)cc1

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BIRC5 O15392 1/20 0.54
PRKD3 O94806 1/20 0.41
PRKCG P05129 1/20 0.41
PRKCB P05771 1/20 0.41
PRKCA P17252 1/20 0.41
PRKACA P17612 1/20 0.41
PRKACG P22612 1/20 0.41
PRKACB P22694 1/20 0.41
PRKCH P24723 1/20 0.41
PRKCI P41743 1/20 0.41
PRKCE Q02156 1/20 0.41
PRKCQ Q04759 1/20 0.41
PRKCZ Q05513 1/20 0.41
PRKCD Q05655 1/20 0.41
PRKD1 Q15139 1/20 0.41
CDK4 P11802 4/20 0.40
CCND1 P24385 4/20 0.40
PLA2G4A P47712 1/20 0.39
PTPN1 P18031 1/20 0.39
CA12 O43570 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL170890 0.85 BIRC5 (0.70) BIRC5PRKD3PRKCGPRKCBPRKCA
SCHEMBL29475118 0.85 BIRC5 (0.70) BIRC5PRKD3PRKCGPRKCBPRKCA
Phosphine SCHEMBL28297804 0.83 BIRC5 (0.68) BIRC5PRKD3PRKCGPRKCBPRKCA
Hydrochloric Acid SCHEMBL3803742 0.83 BIRC5 (0.68) BIRC5PRKD3PRKCGPRKCBPRKCA
Dimethylamine SCHEMBL5608192 0.82 BIRC5 (0.61) BIRC5PRKD3PRKCGPRKCBPRKCA
Hydrochloric Acid SCHEMBL15066336 0.81 BIRC5 (0.66) BIRC5PRKD3PRKCGPRKCBPRKCA
SCHEMBL12160840 0.77 BIRC5 (0.61) BIRC5PRKD3PRKCGPRKCBPRKCA
Aniline SCHEMBL22656869 0.77 BIRC5 (0.59) BIRC5PRKD3PRKCGPRKCBPRKCA
Toluene SCHEMBL23051706 0.75 BIRC5 (0.62) BIRC5PRKD3PRKCGPRKCBPRKCA
Tert-Butyl Formate SCHEMBL28281968 0.74 BIRC5 (0.49) BIRC5PRKD3PRKCGPRKCBPRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050032874-A1 Anticholesterol agents; arteriosclerosis BAYER AKTIENGESELLSCHAFT (DE) 2005-02-10 US disclosed
US-6794406-B2 FOR THERAPY AND PROPHYLAXIS OF ARTERIOSCLEROSIS AND HYPERCHOLESTEROLAEMIA BAYER AKTIENGESELLSCHAFT (DE) 2004-09-21 US disclosed
US-20030078288-A1 Indole derivatives BAYER AKTIENGESELLSCHAFT (DE) 2003-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078288-A1 Indole derivatives IDO1, IDO2, TPH2 BIRC5 457/4885PRKD3 428/4885PRKCG 3354/4885
US-20050032874-A1 Anticholesterol agents; arteriosclerosis HMGCR, CYP46A1, EBP BIRC5 807/4885PRKD3 445/4885PRKCG 759/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.